[HTML][HTML] Antibody–Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System Metastases
DJH Bian, SF Cohen, AM Lazaratos… - Current …, 2024 - pmc.ncbi.nlm.nih.gov
Antibody–drug conjugates (ADCs) represent an emerging class of targeted anticancer
agents that have demonstrated impressive efficacy in numerous cancer types. In non-small …
agents that have demonstrated impressive efficacy in numerous cancer types. In non-small …
Leptomeningeal metastatic disease: new frontiers and future directions
Leptomeningeal metastatic disease (LMD), encompassing entities of 'meningeal
carcinomatosis', neoplastic meningitis' and 'leukaemic/lymphomatous meningitis', arises …
carcinomatosis', neoplastic meningitis' and 'leukaemic/lymphomatous meningitis', arises …
[HTML][HTML] Radiotherapy and Systemic Treatment for Leptomeningeal Disease
Leptomeningeal disease (LMD) is a devastating sequelae of metastatic spread that affects
approximately 5% of cancer patients. The incidence of LMD is increasing due to …
approximately 5% of cancer patients. The incidence of LMD is increasing due to …